Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/120229
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer |
Author: | Milat, F. Goh, S. Gani, L.U. Suriadi, C. Gillespie, M.T. Fuller, P.J. Teede, H.J. Strickland, A.H. Allan, C.A. |
Citation: | Bone, 2013; 55(2):305-308 |
Publisher: | Elsevier |
Issue Date: | 2013 |
ISSN: | 8756-3282 1873-2763 |
Statement of Responsibility: | F. Milat, S. Goh, L.U. Gani, C. Suriadi, M.T. Gillespie, P.J. Fuller, H.J. Teede, A.H. Strickland, C.A. Allan |
Abstract: | Prostate cancer is a leading cause of cancer death, frequently associated with widespread bone metastases. We report two cases of hypocalcemia following the first dose of denosumab in metastatic hormone refractory prostate cancer, the first case requiring 26 days of intravenous calcium therapy. This is the first report of prolonged hypocalcemia following denosumab in a patient with normal renal function. |
Keywords: | Prostate cancer; bone; denosumab; hypocalcemia |
Rights: | Crown Copyright © 2013 Published by Elsevier Inc. All rights reserved. |
DOI: | 10.1016/j.bone.2013.04.012 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1002559 |
Published version: | http://dx.doi.org/10.1016/j.bone.2013.04.012 |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.